Skip to content
HK-2xZFN-mEGFP-Nup107
Tissue
Endocervix
Disease
Adenocarcinoma
Metastatic site
Primary tumor site (endocervix)

Documents

HK-2xZFN-mEGFP-Nup107

Cell line · Product number 300676

The HK-2xZFN-mEGFP-Nup107 cell line is a genetically engineered variant of the Hela Kyoto cell line, derived from human cervical cancer cells. This cell l...

€800.00excl. tax and shipping

Customization / Recommendations

Low stock
Lot
Recommended (freshest lot)
1

01General information

Description

The HK-2xZFN-mEGFP-Nup107 cell line is a genetically engineered variant of the Hela Kyoto cell line, derived from human cervical cancer cells. This cell line has been modified using Zinc Finger Nuclease (ZFN) technology to integrate monomeric Enhanced Green Fluorescent Protein (mEGFP) into the Nup107 gene, a crucial component of the nuclear pore complex (NPC). Nup107 plays a key role in nucleocytoplasmic transport, essential for cellular homeostasis and gene regulation.

The mEGFP integration enables visualization and tracking of Nup107, facilitating studies on the NPC's dynamics and functions. This fluorescent tagging helps understand Nup107's spatial and temporal distribution and its interactions with other nucleoporins and transport factors. The HK-2xZFN-mEGFP-Nup107 cell line is invaluable for researching cellular transport mechanisms and disease pathophysiology.

This cell line provides a robust model for studying the NPC's intricate workings and its health and disease implications, combining the genetic stability and human origin of Hela Kyoto cells with advanced genetic engineering.

Tissue
Endocervix
Disease
Adenocarcinoma
Metastatic site
Primary tumor site (endocervix)
Applications
Nuclear pore complex (NPC) biology; Nup107/Y-complex imaging; nucleocytoplasmic transport; mEGFP live-cell visualization; NPC dynamics; ZFN genome editing validation

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
GMO status
GMO-S1
GMO status details
GMO-S1: This HeLa Kyoto line contains a ZFN-integrated mEGFP fusion at the Nup107 locus enabling nuclear pore complex imaging. This classification applies only within Germany and may differ elsewhere.
Biosafety level
1

03Characteristics

Morphology
Epithelial-like cells with mosaic stone shape
Cell type
Epithelial cells

04Identifiers

Citation
HK-2xZFN-mEGFP-Nup107 (Cytion catalog number 300676)
NCBI TaxID
9606
Cellosaurus
CVCL_VL12
Depositor
The Ellenberg Lab (EMBL)

05Expression and susceptibility

Products
EGFP (Enhanced Green Fluorescent Protein) Nup107

06Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase
Subculturing
Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
Fluid renewal
2 to 3 times per week
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
30 years
Ethnicity
African American